Jamieson Wellness Inc. (TSE:JWEL - Get Free Report)'s stock price shot up 0.8% during trading on Tuesday . The company traded as high as C$36.63 and last traded at C$36.56. 44,964 shares changed hands during trading, a decline of 40% from the average session volume of 75,408 shares. The stock had previously closed at C$36.26.
Analyst Ratings Changes
Separately, Royal Bank of Canada boosted their price target on Jamieson Wellness from C$40.00 to C$42.00 in a report on Friday, May 9th.
Read Our Latest Stock Analysis on JWEL
Jamieson Wellness Trading Down 1.4%
The stock's fifty day moving average price is C$32.98 and its 200 day moving average price is C$33.29. The stock has a market cap of C$1.51 billion, a P/E ratio of 37.89 and a beta of 0.63. The company has a current ratio of 2.76, a quick ratio of 1.08 and a debt-to-equity ratio of 75.70.
Insider Buying and Selling
In other news, Senior Officer Christopher Snowden sold 37,403 shares of the firm's stock in a transaction on Thursday, May 29th. The stock was sold at an average price of C$35.15, for a total transaction of C$1,314,782.78. Also, Senior Officer Joel Scales bought 1,906 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was purchased at an average cost of C$28.34 per share, with a total value of C$54,016.04. Insiders have sold 46,959 shares of company stock valued at $1,651,365 over the last quarter. Corporate insiders own 0.26% of the company's stock.
About Jamieson Wellness
(
Get Free Report)
Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment.
Recommended Stories
Before you consider Jamieson Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.
While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.